NCT04845932

Brief Summary

To identify asthma-related physiological changes observed by wearable devices in real-world conditions by monitor multiple sensing modalities (e.g., heart rate (HR), heart rate variability (HRV), activity level, spirometry, coughing sounds) in order to find reliable signatures of impending asthma exacerbation and systematically explore any challenges on the use of wearable technologies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 31, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 15, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

3.3 years

First QC Date

March 31, 2021

Last Update Submit

March 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identify the correlation between continuous physiological measurements, inhaler usage and lung function outcomes from spirometry

    Physiological measurements obtained from wearable devices (including motion, heart rate and heart rate variability) and from acoustic sensors (including audio from cough) will be correlated with outcomes from the daily spirometry measurements and inhaler use. Hand-crafted and data-driven features will be extracted for physiological measurements. Standard statistical tests will be used to determine significant correlations.

    Continuously from baseline and up to 4 months

Secondary Outcomes (1)

  • Develop a predictive model for asthma exacerbation and drop in lung function based on physiological measurements and inhaler usage

    Continuously from baseline and up to 4 months

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adolescents with asthma will be included

You may qualify if:

  • Adolescents (14-18 years old) with asthma will be included.
  • Participants should have Wireless Internet access at their homes
  • Individuals with COVID-19 symptoms will be automatically excluded due to their clinical screening prior to their clinic visit. However, if a participant contracts COVID-19 during the study, they will be encouraged to continue participating since all interactions will be remote after the first clinical screening.
  • Adolescents should be able to use a iOS device (provided by the researchers) and the devices (with assistance from parents when appropriate) for data collection efforts. They cannot participate in this study if they don't feel comfortable with operating the multiple devices including the iOS device. The iOS device can only be used for the purposes of this study. The iOS device will be restricted by enabling Parental Control Settings accessible only to the researchers.
  • The participation of an adolescent may be terminated by the investigator if they do not follow the guidelines for the study, including using the devices as instructed or participating in the interviews and weekly surveys. Also, the monthly renewal for the participation of the study (up to 4 months) will be decided by the investigators on a month-by-month basis given that the participant also agrees to continue in the study.
  • Individuals with physical challenges are allowed to be incidentally included as long as they satisfy all the previous criteria.

You may not qualify if:

  • none listed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Children's Raleigh Clinic

Raleigh, North Carolina, 27607, United States

RECRUITING

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor - Dept. of Electrical and Computer Engineering

Study Record Dates

First Submitted

March 31, 2021

First Posted

April 15, 2021

Study Start

September 1, 2021

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

March 27, 2024

Record last verified: 2024-03

Locations